The Industry Committee oversees the strategies and activities related to the industry and biotech members of the society. The committee aims to create networking, education and collaboration opportunities by providing a forum for those in industry to meet and discuss areas of interest that are particular to those involved in drug development and taking a product to market.
Kald Abdallah, MD, PhD – Bristol-Myers Squibb
Edward Cha, MD, PhD – Genentech
Jennifer Gansert, MD, PhD - Amgen
Israel Lowy, MD, PhD – Regeneron Pharmaceuticals
Giovanni Melillo, MD – AstraZeneca
Eric Rubin, MD - Merck & Co., Inc.